China Health Group Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Ho Chung
Chief executive officer
HK$1.2m
Total compensation
| CEO salary percentage | 97.9% |
| CEO tenure | 6.6yrs |
| CEO ownership | n/a |
| Management average tenure | 6.5yrs |
| Board average tenure | 8.9yrs |
Recent management updates
Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation
Sep 11
We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet
Sep 23Recent updates
Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation
Sep 11We Think China Health Group (HKG:673) Has A Fair Chunk Of Debt
Dec 01We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet
Sep 23We Think Some Shareholders May Hesitate To Increase China Health Group Limited's (HKG:673) CEO Compensation
Sep 02Did China Health Group Limited (HKG:673) Insiders Sell Shares?
Feb 16
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -HK$40m |
| Dec 31 2023 | n/a | n/a | -HK$35m |
| Sep 30 2023 | n/a | n/a | -HK$29m |
| Jun 30 2023 | n/a | n/a | -HK$36m |
| Mar 31 2023 | HK$1m | HK$1m | -HK$42m |
| Dec 31 2022 | n/a | n/a | -HK$38m |
| Sep 30 2022 | n/a | n/a | -HK$35m |
| Jun 30 2022 | n/a | n/a | -HK$23m |
| Mar 31 2022 | HK$2m | HK$1m | -HK$12m |
| Dec 31 2021 | n/a | n/a | -HK$11m |
| Sep 30 2021 | n/a | n/a | -HK$9m |
| Jun 30 2021 | n/a | n/a | -HK$8m |
| Mar 31 2021 | HK$2m | HK$1m | -HK$8m |
| Dec 31 2020 | n/a | n/a | -HK$23m |
| Sep 30 2020 | n/a | n/a | -HK$38m |
| Jun 30 2020 | n/a | n/a | -HK$37m |
| Mar 31 2020 | HK$2m | HK$1m | -HK$37m |
| Dec 31 2019 | n/a | n/a | -HK$29m |
| Sep 30 2019 | n/a | n/a | -HK$22m |
| Jun 30 2019 | n/a | n/a | -HK$22m |
| Mar 31 2019 | HK$2m | HK$2m | -HK$23m |
| Dec 31 2018 | n/a | n/a | -HK$24m |
| Sep 30 2018 | n/a | n/a | -HK$25m |
| Jun 30 2018 | n/a | n/a | -HK$32m |
| Mar 31 2018 | HK$2m | HK$2m | -HK$39m |
Compensation vs Market: Ho's total compensation ($USD156.95K) is below average for companies of similar size in the Hong Kong market ($USD233.20K).
Compensation vs Earnings: Ho's compensation has been consistent with company performance over the past year.
CEO
Ho Chung (61 yo)
6.6yrs
Tenure
HK$1,226,000
Compensation
Mr. Ho Chung has been an Executive Director at China Health Group Limited since December 28, 2012 and has been its Chief Executive Officer since December 11, 2017. Mr. Chung has an experience in investment...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7.6yrs | HK$1.22m | 28.66% HK$ 129.1m | |
| CEO & Executive Director | 6.6yrs | HK$1.23m | no data | |
| Chief Financial Officer | 6.3yrs | no data | no data | |
| Chief Operating Officer and Vice President | no data | no data | no data | |
| Company Secretary | 15.3yrs | no data | no data | |
| Senior Consultant | 4.8yrs | HK$130.00k | no data |
6.5yrs
Average Tenure
58.5yo
Average Age
Experienced Management: 673's management team is seasoned and experienced (6.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 7.6yrs | HK$1.22m | 28.66% HK$ 129.1m | |
| CEO & Executive Director | 11.6yrs | HK$1.23m | no data | |
| Non-Executive Director | 10.2yrs | HK$101.00k | 0.49% HK$ 2.2m | |
| Non-Executive Director | 2.8yrs | HK$301.00k | 0.029% HK$ 131.4k | |
| Independent Non-Executive Director | no data | HK$101.00k | no data | |
| Non-Executive Director | no data | HK$101.00k | no data | |
| Independent Non-Executive Director | no data | HK$101.00k | no data | |
| Independent Non-Executive Director | no data | HK$101.00k | no data |
8.9yrs
Average Tenure
58.5yo
Average Age
Experienced Board: 673's board of directors are considered experienced (8.9 years average tenure).